Scientific Reports · 2018 · 36 citations · 52 references
MedicineCell BiologyOncologyCell SignalingMetastasisTumor ProgressionCancer Cell SignalingExtracellular MatrixMalignant NeoplasmsProstate CancerTumor InvasionTumor-stroma InteractionsBone Matrix ProteoglycansFocal Adhesion ComplexesFocal Adhesion Kinase SignalingHeparan Sulfate ProteoglycansMetastatic MechanismsProteoglycan DegradationProteoglycans In CancerProteolytic Invasion
Interrupting the interplay between cancer cells and extracellular matrix (ECM) is a strategy to halt tumor progression and stromal invasion. Perlecan/heparan sulfate proteoglycan 2 (HSPG2) is an extracellular proteoglycan that orchestrates tumor angiogenesis, proliferation, differentiation and invasion. Metastatic prostate cancer (PCa) cells degrade perlecan-rich tissue borders to reach bone, including the basement membrane, vasculature, reactive stromal matrix and bone marrow. Domain IV-3, perlecan's last 7 immunoglobulin repeats, mimics native proteoglycan by promoting tumoroid formation. This is reversed by matrilysin/matrix metalloproteinase-7 (MMP-7) cleavage to favor cell dispersion and tumoroid dyscohesion. Both perlecan and Domain IV-3 induced a strong focal adhesion kinase (FAK) dephosphorylation/deactivation. MMP-7 cleavage of perlecan reversed this, with FAK in dispersed tumoroids becoming phosphorylated/activated with metastatic phenotype. We demonstrated Domain IV-3 interacts with the axon guidance protein semaphorin 3A (Sema3A) on PCa cells to deactivate pro-metastatic FAK. Sema3A antibody mimicked the Domain IV-3 clustering activity. Direct binding experiments showed Domain IV-3 binds Sema3A. Knockdown of Sema3A prevented Domain IV-3-induced tumoroid formation and Sema3A was sensitive to MMP-7 proteolysis. The perlecan-Sema3A complex abrogates FAK activity and stabilizes PCa cell interactions. MMP-7 expressing cells destroy the complex to initiate metastasis, destroy perlecan-rich borders, and favor invasion and progression to lethal bone disease.
52
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text
Plexin-Neuropilin-1 Complexes Form Functional Semaphorin-3A Receptors
Takuya Takahashi, Alyson E. Fournier, Fumio Nakamura et al. · Cell · 1999 · 817 citations · Full text
Xia Hong, Richard Seonghun Nho, Judy Kahm et al. · Journal of Biological Chemistry · 2004 · 360 citations · Full text